These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8664301)

  • 1. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
    Gormley NA; Orphanides G; Meyer A; Cullis PM; Maxwell A
    Biochemistry; 1996 Apr; 35(15):5083-92. PubMed ID: 8664301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
    Tsai FT; Singh OM; Skarzynski T; Wonacott AJ; Weston S; Tucker A; Pauptit RA; Breeze AL; Poyser JP; O'Brien R; Ladbury JE; Wigley DB
    Proteins; 1997 May; 28(1):41-52. PubMed ID: 9144789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 4.2 kDa synthetic peptide as a potential probe to evaluate the antibacterial activity of coumarin drugs.
    Scatigno AC; Garrido SS; Marchetto R
    J Pept Sci; 2004 Sep; 10(9):566-77. PubMed ID: 15473264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nucleotide binding to the 43-kilodalton N-terminal fragment of the DNA gyrase B protein.
    Ali JA; Orphanides G; Maxwell A
    Biochemistry; 1995 Aug; 34(30):9801-8. PubMed ID: 7626649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interaction between coumarin drugs and DNA gyrase.
    Maxwell A
    Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing the binding of the coumarin drugs using peptide fragments of DNA gyrase B protein.
    Garrido SS; Scatigno AC; Trovatti E; Carvalho DC; Marchetto R
    J Pept Res; 2005 May; 65(5):502-11. PubMed ID: 15853944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antibiotic microcin B17 is a DNA gyrase poison: characterisation of the mode of inhibition.
    Heddle JG; Blance SJ; Zamble DB; Hollfelder F; Miller DA; Wentzell LM; Walsh CT; Maxwell A
    J Mol Biol; 2001 Apr; 307(5):1223-34. PubMed ID: 11292337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
    Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
    Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
    Wu LC; Shahied SI
    Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the binding of coumarins and cyclothialidines to DNA gyrase.
    Kampranis SC; Gormley NA; Tranter R; Orphanides G; Maxwell A
    Biochemistry; 1999 Feb; 38(7):1967-76. PubMed ID: 10026280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a residue involved in transition-state stabilization in the ATPase reaction of DNA gyrase.
    Smith CV; Maxwell A
    Biochemistry; 1998 Jul; 37(27):9658-67. PubMed ID: 9657678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression in Escherichia coli of Y5 mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1998; 39(1):21-34. PubMed ID: 9473443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.
    Marcu MG; Schulte TW; Neckers L
    J Natl Cancer Inst; 2000 Feb; 92(3):242-8. PubMed ID: 10655441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
    Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
    Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A scintillation proximity assay amenable for screening and characterization of DNA gyrase B subunit inhibitors.
    Gevi M; Domenici E
    Anal Biochem; 2002 Jan; 300(1):34-9. PubMed ID: 11743689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
    Heddle JG; Barnard FM; Wentzell LM; Maxwell A
    Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1249-64. PubMed ID: 11097055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study.
    Holdgate GA; Tunnicliffe A; Ward WH; Weston SA; Rosenbrock G; Barth PT; Taylor IW; Pauptit RA; Timms D
    Biochemistry; 1997 Aug; 36(32):9663-73. PubMed ID: 9245398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 24 kDa N-terminal sub-domain of the DNA gyrase B protein binds coumarin drugs.
    Gilbert EJ; Maxwell A
    Mol Microbiol; 1994 May; 12(3):365-73. PubMed ID: 8065258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression in Escherichia coli of Y5-mutant and N-terminal domain-deleted DNA gyrase B proteins affects strongly plasmid maintenance.
    Brino L; Mousli M; Oudet P; Weiss E
    Plasmid; 1997; 38(3):188-201. PubMed ID: 9435021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Energy coupling in DNA gyrase and the mechanism of action of novobiocin.
    Sugino A; Higgins NP; Brown PO; Peebles CL; Cozzarelli NR
    Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4838-42. PubMed ID: 368801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.